1. Home
  2. JVA vs CASI Comparison

JVA vs CASI Comparison

Compare JVA & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.17

Market Cap

17.8M

ML Signal

HOLD

Logo CASI Pharmaceuticals Inc.

CASI

CASI Pharmaceuticals Inc.

HOLD

Current Price

$0.80

Market Cap

19.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
CASI
Founded
1971
1991
Country
United States
China
Employees
92
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
19.7M
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
JVA
CASI
Price
$3.17
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
61.9K
17.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.57%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.48
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.76
$0.74
52 Week High
$9.93
$3.08

Technical Indicators

Market Signals
Indicator
JVA
CASI
Relative Strength Index (RSI) 45.30 42.05
Support Level $3.00 $0.77
Resistance Level $4.38 $1.07
Average True Range (ATR) 0.14 0.09
MACD 0.03 -0.01
Stochastic Oscillator 83.33 20.69

Price Performance

Historical Comparison
JVA
CASI

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: